XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

18,267 resources

By Version

R2: 52
R2B: 0
R3: 523
R4: 17,252
R4B: 0
R5: 440
R6: 0

By Authority

none: 1,998
hl7: 16,267
national: 2

Start Prev Rows 8200 - 8400 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.835	Lead in Blood (Disorders) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.836	Lead in Blood (Disorders) (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.839	Acid Fast Bacilli (Organism or Substance in Lab Results)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.841	Tuberculosis (Interferon Gamma Release Assays)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.842	Tests by Microscopic Observation in Tissue	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.846	SARS (Tests for SARS_CoV by Culture and Identification Method)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.847	SARS (Tests for SARS_CoV Nucleic Acid)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.86	Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.864	Nausea (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.865	Confusion (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.867	Dyspnea (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.869	Loss of Consciousness (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.87	Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.875	SARS (Organism or Substance in Lab Results)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.878	MERS (Tests for MERS_CoV Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.88	Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.881	Difficulty Breathing (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.884	Tests by Microscopic Observation in Blood	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.889	Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.892	Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.895	Rhinorrhea (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.896	Tests by Microscopic Observation in Blood Smear	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.897	Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.9	Xray of Chest (Imaging)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.90	Cough (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.902	Acute Renal Failure [Unspecified Cause] (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.907	Arthritis [Unspecified Cause] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.91	Cough (SNOMED)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.910	Epididymitis [Unspecified Cause] (SNOMED)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.911	Epididymitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.914	Osteomyelitis [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.915	Osteomyelitis [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.918	Spondylitis [Unspecified Cause] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.919	Arthritis [Unspecified Cause] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.92	Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.927	Thrombocytopenia [Unspecified Cause] (ICD10CM)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.928	Bleeding [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.930	ECG Abnormalities [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.931	Hematemesis [Unspecified Cause] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.932	Hematemesis [Unspecified Cause] (ICD10CM)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.934	Hematuria [Unspecified Cause] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.935	Hemoptysis (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.937	Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.942	Petechiae [Non Traumatic] (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.952	Thrombocytopenia [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.956	Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.957	Regional Lymphadenitis [Including Bubo] (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.958	Regional Lymphadenitis (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.965	Proteinuria [Unspecified Cause] (ICD10CM)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.969	Proteinuria [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.970	Bulbar Weakness (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.971	Bulbar Weakness (ICD10CM)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.976	Dysphagia (SNOMED)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.978	Impaired Respiration [Unspecified Cause] (SNOMED)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.979	Botulism (Organism or Substance in Lab Results)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.98	Shigellosis (Disorders) (SNOMED)	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.989	Tests for Mycobacterium species by Culture and Identification Method	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.994	Organisms (Tests for Nucleic Acid)	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.998	Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.999	Chlamydia species (Organism or Substance in Lab Results)	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.109	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.110	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.112	Pressure Injury Deep Tissue	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.113	Pressure Injury Stage 2, 3, 4 or Unstageable	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.122	Inpatient Falls	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.130	Anticoagulants for VTE Prophylaxis	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.131	Anticoagulants for Indications Other than VTE Prophylaxis	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.160	Abdominal or Pelvic CT Scan with Contrast	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.163	Ultrasound of Lower Extremities	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.164	Ultrasound of Lower Extremities	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.165	Ultrasound of Lower Extremities	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.171	Inpatient Falls	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.183	Anti Factor Xa Assay	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.187	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.188	Extracorporeal Membrane Oxygenation (ECMO)	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.190	Intra Aortic Balloon Pump	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.191	Intra Aortic Balloon Pump	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.193	Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.194	Pressure Injury Deep Tissue Diagnoses	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.196	Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.197	Present on Admission or Clinically Undetermined	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1147.198	Not Present On Admission or Documentation Insufficient to Determine	active	2022-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.1	DEXA Dual Energy Xray Absorptiometry, Bone Density	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.11	Bladder Cancer Staging Ta for Urology Care	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.12	Bladder Cancer staging T1 for Urology Care	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.13	Bladder Cancer staging Tis for Urology Care	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.15	Carcinoma of urinary bladder, superficial	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.16	Injection Leuprolide Acetate	active	2017-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.17	High grade bladder cancer Ta for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.18	Immunocompromised state for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.19	Systemic chemotherapy for urology care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.2	Bladder Cancer in Situ	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.20	Corticosteroids for patients receiving Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.21	Calcineurin inhibitors for patients receiving Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.23	Immunomodulators for patients undergoing Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.24	Monoclonal antibody for patient undergoing Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.28	Radiotherapy for patients undergoing Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.29	Plasmacytoid cell, morphologic abnormality for urology care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.3	Bladder Cancer in Situ	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.30	Sarcomatoid, morphologic abnormality for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.31	Micropapillary, morphologic abnormality, for Urology Care	active	2017-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.32	Immunosuppressive Drugs for Urology Care	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.38	DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care	active	2017-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.39	Mixed histology urothelial cell carcinoma for Urology Care	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.4	BCG Bacillus Calmette Guerin, Tice	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.40	Cystectomy for Urology Care	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.44	Unavailability of Bacillus Calmette Guerin for urology care	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.45	Bladder Cancer for Urology Care	active	2017-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.48	Androgen deprivation therapy for Urology Care	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.5	BCG Bacillus Calmette Guerin, Connaught	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.52	BCG Bacillus Calmette Guerin for Urology Care	active	2020-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.53	Cystectomy for Urology Care	active	2018-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.54	Acute Tuberculosis for Urology Care	active	2018-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.55	Cystectomy for Urology Care	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.56	Active Tuberculosis for Urology Care	active	2018-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.57	Bladder Cancer Staging Tis for Urology Care	active	2019-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.58	Bladder Cancer Staging Tis for Urology Care	active	2019-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.59	Hospital Services for Urology	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.6	Peripheral DXA Scan	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.60	Chemotherapy Agents for Advanced Cancer	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.8	Tuberculosis Diagnosis Prior to Urology Care	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1151.9	Leukemia Diagnosis Prior to Urology Care	active	2016-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.13	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.14	Intensive Lifestyle Interventions	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.15	Intensive Lifestyle Interventions	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.16	Intensive Lifestyle Interventions	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.17	Intensive lifestyle interventions	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.21	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.22	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.23	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.24	Outpatient Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.25	Reason for No Intensive Lifestyle Intervention	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.27	Type 2 Diabetes Diagnoses	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.28	Type 2 Diabetes Diagnoses	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.29	Type 2 Diabetes Diagnoses	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.30	Prediabetes HbA1c Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.31	Prediabetes HbA1c Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.32	Prediabetes HbA1c Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.33	Prediabetes Oral Glucose Tolerance Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.34	Prediabetes Oral Glucose Tolerance Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.35	Prediabetes Oral Glucose Tolerance Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.36	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.37	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.38	Prediabetes Fasting plasma glucose or Plasma Glucose Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.4	Glycemic Screening Tests	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.40	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.41	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.42	Sickle Cell Disease with Vaso Occlusive Episode	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.43	Analgesics for Acute Pain	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.49	Medication Therapy Management Services for Essential Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.5	Glycemic Screening Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.52	Remote Physiologic Blood Pressure Monitoring	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.57	Aldosterone Receptor Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.58	Alpha Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.59	Angiotensin Converting Enzyme Inhibitor for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.6	Glycemic Screening Tests	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.60	Angiotensin II Receptor Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.61	Beta Blocker for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.62	Calcium Channel Blocker Dihydropyridine for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.63	Calcium Channel Blocker Non Dihydropyridine for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.64	Central Acting for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.65	Direct Renin Inhibitor for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.66	Loop Diuretic for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.67	Neuronal Blocking Agent for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.68	Potassium Sparing Diuretic for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.69	Thiazide Diuretic for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.7	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.70	Vasodilator for Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.73	Analgesics for Acute Pain (Non Parenteral Route)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.74	Analgesics for Acute Pain (Parenteral Route)	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.75	Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes	active	2024-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.77	Antihypertensive Medication Classes	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.78	Medication Therapy Management Services for Essential Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.79	Medication Therapy Management Services for Essential Hypertension	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.8	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.84	Renal Colic	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.85	Renal Colic	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.86	Renal Colic	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.88	Direct LDL Cholesterol	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.89	Calculated LDL Cholesterol	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1160.9	Preventative Clinical Encounters	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.50	Urinary retention	active	2017-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.51	Urinary retention	active	2017-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.52	Urinary retention	active	2017-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.65	Morbid Obesity	active	2018-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.66	Morbid Obesity	active	2018-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.67	Morbid Obesity	active	2018-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.68	BMI greater than 40	active	2019-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1164.69	Morbid Obesity	active	2019-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.141	Contraceptive Patch SNOMED Devices	active	2021-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.143	Live Birth Delivery CPT Procedures	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.144	Contraceptive Patch SNOMED Provision Procedures	active	2021-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.145	Contraceptive Patch SNOMED Findings	active	2021-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.146	Contraceptive Patch ICD10CM Provision Encounters	active	2021-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.147	Contraceptive Patch ICD10CM Surveillance	active	2021-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.148	Live Birth Delivery ICD10PCS Procedures	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.149	Contraceptive Patch HCPCS Devices	active	2021-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.15	Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.150	Contraceptive Patch LOINC	active	2021-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1166.152	Live Birth Delivery Procedures SNOMED CT	active	2024-09	hl7